Pfizer (NYSE: PFE) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.53 billion.

GUIDANCE:

• Pfizer sees FY2018 EPS of $2.98-$3.02, versus the consensus of $2.99.
• Now Expect to Repurchase Approximately $12 Billion of Shares in 2018

For earnings history and earnings-related data on Pfizer (PFE) click here.